PQ 1226
1226. Deputy Patrick Costello asked the Minister for Health when publicly funded adjuvant immunotherapy specifically Nivolumab and Pembrolizumab will be available under the public healthcare system as laid out in the National Cancer Strategy 2017-2026. [21648/20]
Introduced
8 September 2020
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
8 September 2020
Summary
1226. Deputy Patrick Costello asked the Minister for Health when publicly funded adjuvant immunotherapy specifically Nivolumab and Pembrolizumab will be available under the public healthcare system as laid out in the National Cancer Strategy 2017-2026. [21648/20]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 8 September 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2020-09-08/1226/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2020-09-08/pq_1226